Clearside Biomedical, Inc. (CLSDQ) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2024 | $1.66M | -79.8% |
| 2023 | $8.23M | +519.9% |
| 2022 | $1.33M | -95.5% |
| 2021 | $29.57M | +274.7% |
| 2020 | $7.89M | +263.3% |
| 2019 | $2.17M | +7143.3% |
| 2018 | $30.0K | -91.3% |
| 2017 | $345.0K | -33.7% |
| 2016 | $520.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2024 | $1.66M | -79.8% |
| 2023 | $8.23M | +519.9% |
| 2022 | $1.33M | -95.5% |
| 2021 | $29.57M | +274.7% |
| 2020 | $7.89M | +263.3% |
| 2019 | $2.17M | +7143.3% |
| 2018 | $30.0K | -91.3% |
| 2017 | $345.0K | -33.7% |
| 2016 | $520.0K | — |